The anemia of inflammation, commonly observed in patients with chronic infections, malignancy, trauma, and inflammatory disorders, is a well-known clinical entity. Until recently, we understood little about its pathogenesis. It now appears that the inflammatory cytokine IL-6 induces production of hepcidin, an iron-regulatory hormone that may be responsible for most or all of the features of this disorder.
Nancy C. Andrews
Title and authors | Publication | Year |
---|---|---|
Oncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients
ML Merchant, AE Gaweda, AJ Dailey, DW Wilkey, X Zhang, BH Rovin, JB Klein, ME Brier |
Kidney International | 2010 |
Cross-talk between iron homeostasis and intestinal inflammation
B Cherayil |
Gut microbes | 2010 |
COMPLETE BLOOD COUNT, MEASURES OF IRON STATUS AND INFLAMMATORY MARKERS IN INNER-CITY AFRICAN AMERICANS WITH UNDIAGNOSED HEPATITIS C SEROPOSITIVITY
Ufearo H, Kambal K, Onojobi GO, Nouraie M, Agbemabiese C, Diaz S, Aggarwal A, Aliyu Z, Taylor RE, Gordeuk VR |
Clinica chimica acta; international journal of clinical chemistry | 2010 |
Efficacy and Safety of Oral Lactoferrin Supplementation in Combination with rHuEPO-β for the Treatment of Anemia in Advanced Cancer Patients Undergoing Chemotherapy: Open-Label, Randomized Controlled Study
Macciò A, Madeddu C, Gramignano G, Mulas C, Sanna E, Mantovani G |
The oncologist | 2010 |